Hirotaka Miyashita, MD (@hirotakamd) 's Twitter Profile
Hirotaka Miyashita, MD

@hirotakamd

Hematology/Oncology and Clinical Pharmacology Fellow at Dartmouth Hitchcock Medical Center

ID: 1403149100867072000

calendar_today11-06-2021 00:36:38

6 Tweet

27 Followers

18 Following

Hirotaka Miyashita, MD (@hirotakamd) 's Twitter Profile Photo

Enjoyed presenting my research regarding the landscape of tratment targets in advanced colon cancer at #AACR2023! Thank you for my mentors at #DHMC, #MCW and #UCSD.

Enjoyed presenting my research regarding the landscape of tratment targets in advanced colon cancer at #AACR2023! Thank you for my mentors at #DHMC, #MCW and #UCSD.
Vivek Subbiah, MD (@viveksubbiah) 's Twitter Profile Photo

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial | Nature Medicine nature.com/articles/s4159…

Yu Fujiwara, MD (@waraonc23) 's Twitter Profile Photo

ASCO abstract titles released! See you all in AM on June 3rd at the Poster hall McCormick Place in Chicago #ASCO23 I'll present our work (#2614) on associations of IDO1 with immune markers as well as it's impact on survival of immune checkpoint inhibitors. #PrecisionMedicine

<a href="/ASCO/">ASCO</a> abstract titles released! See you all in AM on June 3rd at the Poster hall <a href="/McCormick_Place/">McCormick Place</a> in Chicago #ASCO23 I'll present our work (#2614) on associations of IDO1 with immune markers as well as it's impact on survival of immune checkpoint inhibitors. #PrecisionMedicine
Hirotaka Miyashita, MD (@hirotakamd) 's Twitter Profile Photo

Pleased to share a new publication from our group in npj Genomic Medicine with Razelle Kurzrock, MD OmniSeq Heterogeneity is key for precision immunotherapy. doi.org/10.1038/s41525…

Pleased to share a new publication from our group in npj Genomic Medicine with <a href="/Dr_R_Kurzrock/">Razelle Kurzrock, MD</a> <a href="/OmniSeq/">OmniSeq</a> 
Heterogeneity is key for precision immunotherapy.

doi.org/10.1038/s41525…